4//SEC Filing
Lim Bryant David 4
Accession 0001179110-20-008430
CIK 0000861838other
Filed
Jul 22, 8:00 PM ET
Accepted
Jul 23, 4:37 PM ET
Size
5.7 KB
Accession
0001179110-20-008430
Insider Transaction Report
Form 4
Lim Bryant David
SVP & General Counsel
Transactions
- Award
Stock Option (Right to Buy)
2020-07-21+50,000→ 50,000 totalExercise: $2.48Exp: 2030-07-21→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]The stock option award was granted under the Issuer's 2013 Stock Incentive Plan. The stock option vests and becomes exercisable over a four-year period commencing on July 21, 2020. Twenty-five percent (25%) of the stock option vests and becomes exercisable on July 21, 2021 (first anniversary of the date of grant) and the balance vests in twelve equal quarterly installments over the remaining three years of the four-year period, subject to continued service with the Issuer.
Documents
Issuer
IDERA PHARMACEUTICALS, INC.
CIK 0000861838
Entity typeother
Related Parties
1- filerCIK 0001752888
Filing Metadata
- Form type
- 4
- Filed
- Jul 22, 8:00 PM ET
- Accepted
- Jul 23, 4:37 PM ET
- Size
- 5.7 KB